Industry Symposium Sponsored by AstraZeneca: Treatment Option for Unresectable Hepatocellular Carcinoma

Only available as part of a package

This session was recorded as a component of the 2024 Annual Scientific Meeting.

Key:

Complete
Failed
Available
Locked
Industry Symposium Sponsored by AstraZeneca: Treatment Option for Unresectable Hepatocellular Carcinoma
Open to view video.
Open to view video.
You must register to access.